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of this resistance may illuminate critical sites
of the cell-carcinogen interaction.
Cells treated in vitro with N-methyl-N-
nitrosourea, MNU, exhibited malignant trans-
formation and were ten-fold more resistant
to MNU toxicity than previously treated
normal cells. Transformation and resistance
were related and dose dependent. MNU
resistant cells were twice as resistant to
methyl methanesulphonate toxicity and ten-
fold more resistant to the toxic effect of
thymidine, compared wvith normal cells.
Resistance to MNU and thymidine could
not be explained by reduced incorporation,
as measured by the uptake of the respective
radioactively labelled compound. The cross
resistance suggested similar sites may be
involved in MNU and thymidine toxicity.
(Studies performed at the Paterson Labora-
tories, Christie Hospital, Manchester.)
INHIBITION OF THE EFFECTS OF
METHYLCHOLANTHRENE BY VITA-
MIN A AND VITAMIN A ANALOGUES,
Ilse Lasnitzki and De Witt S. Goodman,
Strangeways Research Laboratory, Cam-
bridge.
Retinol and retinoic acid have been shown
to inhibit carcinogenesis in vitro and in vivo
but their possible clinlical use may be limited
by their high toxicity. Vitamin A analogues
without the biological properties of the
natural vitamin may serve as substitutes.
The influence of two analogues, ox-retinoic
acid and anhydroretinoic acid, on the effect
of methylcholanthrene was examined in
mouse prostates grown in vitro and compared
with that of retinol and retinoic acid.
The carcinogen alone induced extensive
epithelial hyperplasia and dysplasia. All
four compounds, applied at various dose
levels, were highly active in inhibiting this
effect. At the highest concentration they
almost totally suppressed the hyperplasia, at
the lowest concentration retinoic acid and
anhydroretinoic acid were the most effective
inhibitors. Mechanisms involved in the
antagonism have been investigated.
IMMUNOGENICITY OF EMBRYONIC
ANTIGENS ASSOCIATED WITH
CHEMICALLY INDUCED RAT TU-
MOURS, R. W. Baldwin and B. M. Vose,
Cancer Research Laboratories, University of
Nottingham.
Chemically induced rat hepatomata and
sarcomata express neoantigens at the cell
surface which are also detectable on mid-
gestation rat embryo cells. These antigens
are revealed by the cytotoxicity ofserum and
lymph node cells from multiparous female
rats for embryo and tumour cells by serum
from these animals. Since the multiparous
rat becomes sensitized to these antigens, they
are immunogenic when expressed on embryo
cells in the pregnant host. Immunization of
syngeneic rats with mid-gestation rat emblryo
cells failed, however, to elicit immunity to
challenge with hepatomata or sarcomata.
Also, lymphoid cells from multiparous rats
were ineffective for adoptively transferring
tumour immunity. These studies are dis-
cussed in connection with the view that the
tumour specific rejection antigens on these
tumours differ from the tumour associated
embryonic antigens.
"WILD" TYPE ANTIGENS OF SAR-
COMATA INDUCED BY A NATURAL
AMINE SARCOMA VIRUS (MSV-FBJ),
David B. Jones and Michael Moore, Charles
Salt Research Centre, The Robert Jones and
Agnes Hunt Orthopaedic Hospital, Oswestry.
MSV-FBJ is a C-type murine oncorna-
virus which induces primitive mesenchymal
sarcomata of long latency in mice. The
agent was originally isolated from a sponta-
neous murine osteosarcoma and is of demon-
strated " wild " type antigencity.
Transplantation rejection techniques have
demonstrated a tumour associated antigen
common to all cells transformed by MSV-FBJ
and also present on cells infected with " wild "
type Gross leukaemia virus. The specificity
was absent from cells transformed by the
" non-wild " type isolate MSV-Harvey (MSV-
H).
Serum from mice immunized against
MSV-FBJ sarcoma cells reacted in the
indirect membrane immunofluorescence test
with both MSV-FBJ sarcoma cells and Gross
antigen bearing cells, but not with the
membrane of MSV-H cells. Further, aged
C57B1 serum specifically reactivewithcellular
rather than virion specificities of Gross virus
infected cells reacted with MSV-FBJ sarcoma
cells. Identification ofantigens onthe surface
of MSV-FBJ sarcoma cells which were not
also present on " wild " type antigen-bearing
tumours could not be achieved by absorption
techniques.